David Toung
Stock Analyst at Argus Research
(4.41)
# 328
Out of 4,667 analysts
118
Total ratings
68.48%
Success rate
11.15%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Upgrades: Buy | n/a | $166.57 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $118.33 | +5.64% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $577.00 | +3.99% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $186.10 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $279.95 | +21.45% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $615.65 | +8.83% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $110.95 | +35.20% | 7 | May 21, 2024 | |
| LLY Eli Lilly | Maintains: Buy | $770 → $840 | $729.73 | +15.11% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $78.57 | +20.91% | 1 | May 9, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $82.52 | +33.30% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $236.23 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.10 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $277.78 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $509.12 | +8.03% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $62 | $58.88 | +5.30% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.88 | - | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $388.68 | -20.24% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $335.11 | -7.49% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $538.82 | -40.61% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $117.13 | +15.26% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $87.75 | -14.53% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $58.23 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $96.54 | +13.94% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $85.00 | +94.12% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.93 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $66.37 | +84.57% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $63.80 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.27 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $153.00 | +1.31% | 4 | Mar 27, 2020 |
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $166.57
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $118.33
Upside: +5.64%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $577.00
Upside: +3.99%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $186.10
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $279.95
Upside: +21.45%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $615.65
Upside: +8.83%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $110.95
Upside: +35.20%
Eli Lilly
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $729.73
Upside: +15.11%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $78.57
Upside: +20.91%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $82.52
Upside: +33.30%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $236.23
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.10
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $277.78
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $509.12
Upside: +8.03%
Sep 5, 2023
Upgrades: Buy
Price Target: $62
Current: $58.88
Upside: +5.30%
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $22.88
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $388.68
Upside: -20.24%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $335.11
Upside: -7.49%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $538.82
Upside: -40.61%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $117.13
Upside: +15.26%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $87.75
Upside: -14.53%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $58.23
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $96.54
Upside: +13.94%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $85.00
Upside: +94.12%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.93
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $66.37
Upside: +84.57%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $63.80
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $103.27
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $153.00
Upside: +1.31%